FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,764,193 | -54.7% | 1,775,344 | +1.7% | 0.00% | -100.0% |
| Q2 2023 | $8,306,737 | -9.6% | 1,745,112 | +8.2% | 0.00% | 0.0% |
| Q1 2023 | $9,191,763 | +58138.4% | 1,612,589 | +3.1% | 0.00% | -50.0% |
| Q4 2022 | $15,783 | -100.0% | 1,564,291 | +4.3% | 0.00% | -60.0% |
| Q3 2022 | $33,607,000 | -7.5% | 1,499,680 | +2.3% | 0.01% | 0.0% |
| Q2 2022 | $36,319,000 | -36.5% | 1,465,678 | -0.6% | 0.01% | -28.6% |
| Q1 2022 | $57,155,000 | -31.5% | 1,474,227 | +3.4% | 0.01% | -30.0% |
| Q4 2021 | $83,433,000 | +0.3% | 1,425,968 | +1.6% | 0.01% | -9.1% |
| Q3 2021 | $83,220,000 | -32.4% | 1,404,096 | -1.0% | 0.01% | -35.3% |
| Q2 2021 | $123,103,000 | +10.7% | 1,418,406 | +5.1% | 0.02% | 0.0% |
| Q1 2021 | $111,250,000 | +5.5% | 1,349,312 | +16.4% | 0.02% | -5.6% |
| Q4 2020 | $105,434,000 | +139.0% | 1,159,514 | +5.1% | 0.02% | +100.0% |
| Q3 2020 | $44,106,000 | +24.6% | 1,103,490 | +7.0% | 0.01% | +12.5% |
| Q2 2020 | $35,384,000 | +67.9% | 1,031,326 | +8.7% | 0.01% | +60.0% |
| Q1 2020 | $21,072,000 | -38.6% | 948,788 | -45.9% | 0.01% | +25.0% |
| Q4 2019 | $34,318,000 | +172.0% | 1,753,670 | +115.8% | 0.00% | +33.3% |
| Q3 2019 | $12,618,000 | -22.6% | 812,533 | +1.2% | 0.00% | -25.0% |
| Q2 2019 | $16,299,000 | +17.3% | 802,953 | +1.5% | 0.00% | 0.0% |
| Q1 2019 | $13,895,000 | -22.9% | 790,871 | -43.7% | 0.00% | +33.3% |
| Q4 2018 | $18,016,000 | +114.7% | 1,404,358 | +172.6% | 0.00% | +50.0% |
| Q3 2018 | $8,393,000 | +63.4% | 515,252 | +13.8% | 0.00% | 0.0% |
| Q2 2018 | $5,136,000 | +30.1% | 452,926 | +11.9% | 0.00% | +100.0% |
| Q1 2018 | $3,949,000 | +86.0% | 404,634 | +16.4% | 0.00% | 0.0% |
| Q4 2017 | $2,123,000 | +77.4% | 347,573 | +14.9% | 0.00% | – |
| Q3 2017 | $1,197,000 | +108.9% | 302,431 | +70.8% | 0.00% | – |
| Q2 2017 | $573,000 | +5.5% | 177,082 | +48.2% | 0.00% | – |
| Q1 2017 | $543,000 | +87.9% | 119,514 | +3.6% | 0.00% | – |
| Q4 2016 | $289,000 | -14.2% | 115,416 | +6.8% | 0.00% | – |
| Q3 2016 | $337,000 | +84.2% | 108,093 | +0.1% | 0.00% | – |
| Q2 2016 | $183,000 | -5.7% | 108,029 | 0.0% | 0.00% | – |
| Q1 2016 | $194,000 | -46.7% | 108,029 | -0.1% | 0.00% | – |
| Q4 2015 | $364,000 | -36.7% | 108,093 | +0.1% | 0.00% | – |
| Q3 2015 | $575,000 | +14.1% | 107,965 | +38.5% | 0.00% | – |
| Q2 2015 | $504,000 | +227.3% | 77,947 | +146.9% | 0.00% | – |
| Q1 2015 | $154,000 | -1.9% | 31,576 | +0.6% | 0.00% | – |
| Q4 2014 | $157,000 | -1.9% | 31,384 | +0.6% | 0.00% | – |
| Q3 2014 | $160,000 | +7.4% | 31,192 | +31.8% | 0.00% | – |
| Q2 2014 | $149,000 | -35.5% | 23,664 | -0.3% | 0.00% | – |
| Q1 2014 | $231,000 | – | 23,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |